Responses
Clinical and epidemiological research
Concise report
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
Compose a Response to This Article
Other responses
No responses have been published for this article.